Taro Pretax Profit Margin from 2010 to 2024

TARO Stock  USD 42.48  0.08  0.19%   
Taro Pharmaceutical Pretax Profit Margin yearly trend continues to be very stable with very little volatility. Pretax Profit Margin is likely to grow to 0.47 this year. During the period from 2010 to 2024, Taro Pharmaceutical Pretax Profit Margin quarterly data regression pattern had range of 1.3864 and standard deviation of  0.35. View All Fundamentals
 
Pretax Profit Margin  
First Reported
2010-12-31
Previous Quarter
0.44364203
Current Value
0.47
Quarterly Volatility
0.34908087
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Taro Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Taro main balance sheet or income statement drivers, such as Total Revenue of 356.7 M, Gross Profit of 235.8 M or Other Operating Expenses of 670.4 M, as well as many exotic indicators such as Price To Sales Ratio of 2.36, Dividend Yield of 0.0 or PTB Ratio of 3.72. Taro financial statements analysis is a perfect complement when working with Taro Pharmaceutical Valuation or Volatility modules.
  
This module can also supplement Taro Pharmaceutical's financial leverage analysis and stock options assessment as well as various Taro Pharmaceutical Technical models . Check out the analysis of Taro Pharmaceutical Correlation against competitors.

Latest Taro Pharmaceutical's Pretax Profit Margin Growth Pattern

Below is the plot of the Pretax Profit Margin of Taro Pharmaceutical Industries over the last few years. It is Taro Pharmaceutical's Pretax Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Taro Pharmaceutical's overall financial position and show how it may be relating to other accounts over time.
Pretax Profit Margin10 Years Trend
Slightly volatile
   Pretax Profit Margin   
       Timeline  

Taro Pretax Profit Margin Regression Statistics

Arithmetic Mean0.39
Coefficient Of Variation89.44
Mean Deviation0.22
Median0.47
Standard Deviation0.35
Sample Variance0.12
Range1.3864
R-Value(0.40)
Mean Square Error0.11
R-Squared0.16
Significance0.13
Slope(0.03)
Total Sum of Squares1.71

Taro Pretax Profit Margin History

2024 0.47
2022 0.0667
2021 0.14
2020 -0.71
2019 0.46
2018 0.53

About Taro Pharmaceutical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Taro Pharmaceutical income statement, its balance sheet, and the statement of cash flows. Taro Pharmaceutical investors use historical funamental indicators, such as Taro Pharmaceutical's Pretax Profit Margin, to determine how well the company is positioned to perform in the future. Although Taro Pharmaceutical investors may use each financial statement separately, they are all related. The changes in Taro Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Taro Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Taro Pharmaceutical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Taro Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.44  0.47 

Currently Active Assets on Macroaxis

When determining whether Taro Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Taro Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Taro Pharmaceutical Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Taro Pharmaceutical Industries Stock:
Check out the analysis of Taro Pharmaceutical Correlation against competitors.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Taro Stock analysis

When running Taro Pharmaceutical's price analysis, check to measure Taro Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taro Pharmaceutical is operating at the current time. Most of Taro Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Taro Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taro Pharmaceutical's price. Additionally, you may evaluate how the addition of Taro Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Taro Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taro Pharmaceutical. If investors know Taro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Taro Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.782
Earnings Share
1.22
Revenue Per Share
16.252
Quarterly Revenue Growth
0.129
Return On Assets
0.0103
The market value of Taro Pharmaceutical is measured differently than its book value, which is the value of Taro that is recorded on the company's balance sheet. Investors also form their own opinion of Taro Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Taro Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taro Pharmaceutical's market value can be influenced by many factors that don't directly affect Taro Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taro Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taro Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taro Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.